Tumor growth status in the subcutaneous xenograft mouse model showed that the STEAP2 reactivation group had slower tumor volume growth rate, smaller tumors, and lower final tumor weight than the NC groups (Fig. 4A–C). This evidence concerns the gene STEAP2 and neoplasm.